Christian C. Ruff

2 weeks ago | ajmc.com | Giuliana Grossi |Christian C. Ruff |John B. Buse |Marc P. Bonaca |Marc Humbert |Jawad Haider Butt | +1 more

At the American College of Cardiology Annual Scientific Session (ACC.25), experts shared groundbreaking research poised to reshape cardiovascular care—particularly for women and patients with complex cardiometabolic conditions.

3 weeks ago | ajmc.com | Giuliana Grossi |Christian C. Ruff

New data comparing abelacimab (MAA868) with rivaroxaban (Xarelto) in patients with atrial fibrillation (AF) were presented at the American College of Cardiology 2025 Annual Scientific Session (ACC.25). The American Journal of Managed Care® spoke with AZALEA-TIMI 71 (NCT04755283) study investigator Christian T. Ruff, MD, MPH, director of Genetics Core Laboratory, and assistant professor of medicine at Harvard Medical School, Brigham and Women’s Faulkner Hospital, in Boston.